What’s going on here? The Dow Jones took a nosedive, plunging over 1,450 points, as tariff fears and potential interest rate changes sent shockwaves through global markets, fueling trade tensions and ...

What’s going on here? Tech giants are under pressure as President Trump's tariffs send shockwaves through the market, affecting ETFs and key players like Apple, Tesla, and Meta. The tech sector is in ...

What’s going on here? Earnings reports from players like Walgreens, Delta, and JPMorgan are poised to steer market sentiments, offering fresh insights into sector health and economic challenges.

What’s going on here? European shares nosedived this week, with the STOXX index sliding 4.4% after the US imposed new tariffs, fueling broad recession worries. The US imposed a 20% import tariff on ...

What’s going on here? March brought unexpected joy to the US job market as nonfarm payrolls jumped by 228,000 – beating the forecast of 144,000 – despite earlier downward revisions. The US job market ...

Join the newsletter that everyone in finance secretly reads. 1M+ subscribers, 100% free. Bausch + Lomb is set to release its Q1 2025 financial report on April 30, with investors focusing on its ...

What’s going on here? Recent US-China trade tensions have ignited a significant sell-off, with exchange-traded funds (ETFs) across various sectors feeling the heat of market chaos. China's response to ...

What’s going on here? This week, energy stocks were battered as oil and gas prices plummeted, leading to sharp declines in major indices and significant drops in the shares of industry leaders. The ...

Join the newsletter that everyone in finance secretly reads. 1M+ subscribers, 100% free. The tech world is buzzing as Elon Musk prepares for a courtroom showdown with OpenAI, the AI behemoth he ...

What’s going on here? Mustafa Suleyman, the genius behind Microsoft's AI vision, is focusing on the successful session rate (SSR) to boost the user experience of Copilot, their AI companion.

What’s going on here? The US dollar is flexing against the Canadian loonie, holding steady and poised for a high-level consolidation following its rally in late February. Rosenberg Research's analysis ...

What’s going on here? European stocks listed in the US faced harsh drops, especially financial services, while Biodexa Pharmaceuticals emerged as a rare bright spot. The S&P Europe Select ADR Index ...